Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Current Cancer Drug Targets|January 29, 2024
Recent Progress in the Application of Exosome Analysis in Ovarian Cancer ManagementVahideh Keyvani, Zari Naderi Ghale-Noie, Samaneh Mollazadeh, et al.
Current Pharmaceutical Design|November 2, 2023
Insight into RNA-based Therapies for Ovarian CancerVahideh Keyvani, Reihaneh Alsadat Mahmoudian, Samaneh Mollazadeh, et al.
Frontiers in Oncology|September 3, 2024
Pathologic response evaluation of localized or locally advanced esophageal carcinoma to induction chemotherapy followed by preoperative concurrent chemotherapy and hypofractionated radiotherapy: a clinical trialAli Emadi Torghabeh, Seyed Amir Aledavood, Ehsan Soltani, et al.
German Medical Science : GMS E-Journal|March 23, 2017
A comprehensive approach in high-grade glioma management: position statement from the Neuro-Oncology Scientific Club (NOSC), Shiraz, IranMansour Ansari, Ahmad Mosalaei, Niloufar Ahmadloo, et al.
Current Pharmaceutical Design|March 19, 2024
The Application of Nanotechnological Therapeutic Platforms against Gynecological CancersVahideh Keyvani, Samaneh Mollazadeh, Espanta Riahi, et al.
Pharmacogenomics|April 10, 2018
A genetic polymorphism in the CYP1B1 gene in patients with squamous cell carcinoma of the esophagus: an Iranian Mashhad cohort study recruited over 10 yearsAzam Rastgar Moghadam, Mehrane Mehramiz, Malihe Entezari, et al.
Life Sciences|June 19, 2023
Dual targeting of TGF-β and PD-L1 inhibits tumor growth in TGF-β/PD-L1-driven colorectal carcinomaGhazaleh Khalili-Tanha, Hamid Fiuji, Masoumeh Gharib, et al.
Journal of Cellular Physiology|September 22, 2018
A genetic variant in CDKN2A/2B locus was associated with poor prognosis in patients with esophageal squamous cell carcinomaNiloofar Ghobadi, Mehrane Mehramiz, Soodabeh ShahidSales, et al.
Expert Opinion on Drug Safety|July 30, 2024
Safety evaluation of the trastuzumab biosimilar in Iranian women with HER2-positive breast cancer undergoing adjuvant chemotherapy: a post-marketing surveillanceFatemeh Zahedi, Anya Jafari, Behnam Nasiri Motlagh, et al.
Pageof 6